Skip to main content Skip to search Skip to main navigation

MDR: Proposal for a delay due to Covid-19

The deadline of 26 May 2020 should have been the date: The European Commission's Medical Device Regulation (MDR) was supposed to come into force. Due to the Corona crisis, the European Commission is now submitting a proposal to postpone the implementation deadline.

Other organisations had already called for this step:

Medical device manufacturers have repeatedly questioned whether the deadline can be met, as there is still a lack of Notified Bodies. The introduction of laws to ensure compliance with the new product standards was also critical in terms of timing (we reported).

In a press release of 23 March 2020, MedTech Europe called for a postponement of the introduction date for MDR and IVDR. Their proposal: Six months after the crisis has been overcome, the implementation should be resumed.

In a letter of 24 March 2020, six Members of the European Parliament address the lack of resources caused by the current crisis in the following areas:

  • Approval of clinical trials
  • Notification and auditing of Notified Bodies
  • Manufacturing

The Members of Parliament are calling to maintain the current system for regulating medical devices. Health systems across Europe need all their resources to deal with the corona crisis.

The proposal for postponement should be submitted in early April and implemented as soon as possible. This information is according to a Q&A session at the European Commission press conference of 25 March 2020.


Sources:

MedTech Europe: Press release

European Commission: Letter of the European Parliament

European Commission: Q&A Press conference Covid-19 and MDR

 

Meet the GMP Compliance Adviser

The GMP Compliance Adviser is the world's largest knowledge portal for quality management in the pharma business. 

The demo access is non-binding and ends automatically.

Test it now for free

You may also be Interested in the Following Articles:

PIC/S: Jordan FDA Joins PIC/S

PIC/S: Jordan FDA Joins PIC/S

On 1 January 2026, the Jordan Food & Drug Administration (JFDA) became the 57th PIC/S Participating Authority.

Read more
Swissmedic: Scientific GMDP Meetings

Swissmedic: Scientific GMDP Meetings

Swissmedic offers companies holding or seeking a Swissmedic manufacturing or distribution license the opportunity to discuss project-specific GMP and GDP topics in Scientific GMDP Meetings.

Read more
Purified Water – The new Chinese Pharmacopoeias and What Happens Next? NEU

Purified Water – The new Chinese Pharmacopoeias and What Happens Next? NEU

A new Chinese Pharmacopoeia was published in 2025. This has some significant implications for the pharmaceutical water industry, which we will discuss in more detail in this article. Firstly, it is important to note that cold WFI systems are now permitted worldwide and can be used across the board.
Read more
What are the requirements for gas distribution systems?

What are the requirements for gas distribution systems?

You can view the answer here:
Read more
What are the quality requirements for pharmaceutical gases?

What are the quality requirements for pharmaceutical gases?

You can view the answer here:
Read more
EMA: Update on the Guideline “Stability Testing for Variations”

EMA: Update on the Guideline “Stability Testing for Variations”

The EMA has updated the guideline on stability testing for variations (Revision 3, applicable from 15 January 2026).
Read more
Previous
Next